Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults

NCT06745921 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

NIH

Sponsor class

Conditions

West Nile Viral Infection

Interventions

BIOLOGICAL: HydroVax-001B WNV
OTHER: Placebo
OTHER: Sodium Chloride, 0.9%

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)